The impact of faster antimicrobial susceptibility testing report and dual antimicrobial susceptibility testing cards on the antibiotic therapy and economics of hospitalized bloodstream infection patients

Optimized microbiology workflows, including dual AST cards and faster AST report, significantly accelerated reporting and facilitated timely, precise antimicrobial therapy, particularly carbapenem stewardship, while reducing clinical and economic burdens.